Literature DB >> 21963310

Postpartum intrauterine device insertion and postpartum tubal sterilization in the United States.

Maura K Whiteman1, Shanna Cox, Naomi K Tepper, Kathryn M Curtis, Denise J Jamieson, Ana Penman-Aguilar, Polly A Marchbanks.   

Abstract

OBJECTIVE: The purpose of this study was to estimate US rates of postpartum intrauterine device (IUD) insertion and postpartum tubal sterilization. STUDY
DESIGN: Data from the 2001-2008 Nationwide Inpatient Sample were used to identify delivery hospitalizations with IUD insertion or tubal sterilization procedure codes.
RESULTS: Estimated rates of postpartum IUD insertion and postpartum tubal sterilization were 0.27 and 770.67 per 10,000 deliveries, respectively. Although the rate of IUD insertion was similar across age groups, the rate of tubal sterilization increased with age. Nonetheless, 15% of tubal sterilizations occurred among women who were ≤ 24 years old. IUD insertion was more likely among women who delivered at teaching hospitals (odds ratio, 3.02; 95% confidence interval, 1.43-6.37); tubal sterilization was more likely among women without private insurance (odds ratio, 2.04; 95% confidence interval, 1.97-2.11).
CONCLUSION: Among US postpartum women, IUD insertion occurs considerably less frequently than tubal sterilization, even among younger women for whom poststerilization regret is a concern. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21963310     DOI: 10.1016/j.ajog.2011.08.004

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.

Authors:  Michelle H Moniz; Tammy Chang; Michele Heisler; Lindsay Admon; Acham Gebremariam; Vanessa K Dalton; Matthew M Davis
Journal:  Obstet Gynecol       Date:  2017-06       Impact factor: 7.661

2.  Policy change is not enough: engaging provider champions on immediate postpartum contraception.

Authors:  Ekwutosi M Okoroh; Debra J Kane; Rebekah E Gee; Lyn Kieltyka; Brittni N Frederiksen; Katharyn M Baca; Kristin M Rankin; David A Goodman; Charlan D Kroelinger; Wanda D Barfield
Journal:  Am J Obstet Gynecol       Date:  2018-03-09       Impact factor: 8.661

3.  Immediate postpartum long-acting reversible contraception: the time is now.

Authors:  Michelle Moniz; Tammy Chang; Michele Heisler; Vanessa K Dalton
Journal:  Contraception       Date:  2016-11-29       Impact factor: 3.375

4.  Contraceptive counseling and postpartum contraceptive use.

Authors:  Lauren B Zapata; Sarah Murtaza; Maura K Whiteman; Denise J Jamieson; Cheryl L Robbins; Polly A Marchbanks; Denise V D'Angelo; Kathryn M Curtis
Journal:  Am J Obstet Gynecol       Date:  2014-08-02       Impact factor: 8.661

5.  Variation in postpartum contraceptive method use: results from the Pregnancy Risk Assessment Monitoring System (PRAMS).

Authors:  Kari White; Joseph E Potter; Kristine Hopkins; Daniel Grossman
Journal:  Contraception       Date:  2013-10-22       Impact factor: 3.375

6.  Geographic Variation in Characteristics of Postpartum Women Using Female Sterilization.

Authors:  Kari White; Joseph E Potter; Nikki Zite
Journal:  Womens Health Issues       Date:  2015-07-29

7.  Medicaid Payments For Immediate Postpartum Long-Acting Reversible Contraception: Evidence From South Carolina.

Authors:  Maria W Steenland; Lydia E Pace; Anna D Sinaiko; Jessica L Cohen
Journal:  Health Aff (Millwood)       Date:  2021-02       Impact factor: 9.048

8.  Assessing the Barriers to Postpartum Tubal Ligation Among Multiparous Women.

Authors:  Avir Sarkar; Maninder K Ghotra; Isha Wadhawan; Sonam Jindal; Rinchen Zangmo; Abhik Sarkar
Journal:  Cureus       Date:  2022-08-02

9.  Barriers to Postpartum Contraception in Texas and Pregnancy Within 2 Years of Delivery.

Authors:  Joseph E Potter; Celia Hubert; Amanda Jean Stevenson; Kristine Hopkins; Abigail R A Aiken; Kari White; Daniel Grossman
Journal:  Obstet Gynecol       Date:  2016-02       Impact factor: 7.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.